Cancer Research Center of Toulouse at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Cancer Research Center of Toulouse brings 2 presentations to ASH 2026 in New Orleans. Its program centres on why leukemia and myeloma cells resist treatment. It covers chemoresistance in acute myeloid leukemia and the natural history of smoldering myeloma.
| Organization | ASH 2026 Attendance |
|---|---|
Cancer Research Center of Toulouse Toulouse, France | |
Cancer research institute in Toulouse, France, run by Inserm, CNRS and the University of Toulouse. | Session Fri Dec 11 3:00pm–6:00pm Scientific Workshop on Mitochondria and Metabolism in Blood Cancer - From Discovery to Patients Mitochondria and cell metabolism as drivers of blood cancer survival, with practical ways to test metabolic weak points and carry them into trials. Talk Sat Dec 12 8:00am–9:00am Talk Sun Dec 13 9:30am–10:45am Biological Insights into Resistant Cells Leukemia cells that survive treatment and seed relapse lean on mitochondrial energy production, and their metabolic and surface features could be drug targets. |
Find decision makers at Cancer Research Center of Toulouse
Tell us what you sell and we’ll find the people at Cancer Research Center of Toulouse most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction